Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit (INFLA-SEPSIS)

NCT04635878 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04635878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04635878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit (INFLA-SEPSIS)
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
July 27, 2020
Completion date
May 30, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis